ACHILLES THERAPEUTICS PL-ADR (ACHL) Stock Price, Quote, News and Overview
NASDAQ:ACHL - Nasdaq - US00449L1026 - ADR - Currency: USD
ACHL Quote, Performance and Key Statistics
ACHILLES THERAPEUTICS PL-ADR
NASDAQ:ACHL (2/4/2025, 6:38:40 PM)
After market: 1.35 -0.01 (-0.74%)1.36
+0.24 (+21.43%)
The current stock price of ACHL is 1.36 USD. In the past month the price increased by 17.27%. In the past year, price increased by 44.68%.
ACHL Latest News, Press Releases and Analysis
Discover the top movers in Tuesday's pre-market session.
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts
Achilles Therapeutics announces a $12M deal with AstraZeneca for TRACERx data and plans job cuts following its strategic review.
Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
- Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be transferred to AstraZeneca under the Transaction - ...
Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
LONDON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced that on November 15, 2024, the Listing Qualifications...
Achilles Therapeutics Reports Third Quarter 2024 Financial Results
– Cash position of $86.1 million as of September 30, 2024, not including cash R&D tax credit of $12.8 million received in October 2024 – ...
ACHL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.77 | 335.67B | ||
| AMGN | AMGEN INC | 15.04 | 155.36B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 945.65 | 124.20B | ||
| GILD | GILEAD SCIENCES INC | 22.12 | 122.12B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.60B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.95B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.08B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.76B | ||
| NTRA | NATERA INC | N/A | 23.00B | ||
| BIIB | BIOGEN INC | 8.73 | 20.76B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.52 | 15.78B |
Related stock screener links
About ACHL
Company Profile
Achilles Therapeutics Plc is a biopharmaceutical company engages in developing transformative precision T-cell therapies to treat multiple types of solid tumors. The firm is engaged in developing precision T cell therapies to treat multiple types of solid tumors. Its lead product is a precision tumor-derived T cell therapy targeting clonal cancer neoantigens. Its pipeline includes Chiron: Advanced Non-Small Cell Lung Cancer, Thetis: Melanoma (Monotherapy), Thetis: Melanoma (PD-1 Combination), and other indications. The company is focused on advancing cancer therapies through its work in the field of tumor evolution. Its platform enables to identify mutations formed early in the development of a cancer that give rise to antigens that are expressed by all of a patient's cancer cells but are absent from healthy tissue. The company refers to this class of solid tumor targets as clonal neoantigens. To identify clonal neoantigens in a patient, it has developed a bioinformatic platform called PELEUS.
Company Info
ACHILLES THERAPEUTICS PL-ADR
245 Hammersmith Road, Gunnels Wood Road
London W6 8PW GB
CEO: Iraj Ali
Employees: 210
Company Website: https://www.achillestx.com/
Investor Relations: https://ir.achillestx.com/
Phone: 442081544600
ACHL FAQ
What is the stock price of ACHL?
The current stock price of ACHL is 1.36 USD.
What is the symbol for ACHILLES THERAPEUTICS PL-ADR stock?
The exchange symbol of ACHILLES THERAPEUTICS PL-ADR is ACHL and it is listed on the Nasdaq exchange.
On which exchange is ACHL stock listed?
ACHL stock is listed on the Nasdaq exchange.
Is ACHL a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ACHL, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ACHL.
Does ACHL stock pay dividends?
ACHL does not pay a dividend.
What is the Price/Earnings (PE) ratio of ACHL?
ACHL does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.65).
What is the Short Interest ratio of ACHL stock?
The outstanding short interest for ACHL is 0.31% of its float.
ACHL Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ACHL. When comparing the yearly performance of all stocks, ACHL is one of the better performing stocks in the market, outperforming 90.89% of all stocks.
ACHL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ACHL. ACHL has a great financial health rating, but its profitability evaluates not so good.
ACHL Financial Highlights
Over the last trailing twelve months ACHL reported a non-GAAP Earnings per Share(EPS) of -1.65. The EPS increased by 12.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -54.52% | ||
| ROE | -64.84% | ||
| Debt/Equity | 0 |
ACHL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to ACHL. The Buy consensus is the average rating of analysts ratings from 9 analysts.